LegiList
Congress, Made Clear.
Home
My LegiList
Browse
Legislators
Bills
Laws
Committees
Campaign Finance
Analytics
Weekly Briefing
Support LegiList
For past Congresses, use the Browse menu.
HR 2297
118th Congress • 2023–2025 (Ended)
To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.
Full Bill Page
Lobbying Summary
Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…